Literature DB >> 21934604

In-vivo cancer cell destruction using porous silicon nanoparticles.

Chanseok Hong1, Jungkeun Lee, Mikwon Son, Soon Sun Hong, Chongmu Lee.   

Abstract

In-vivo animal tests were performed to investigate the feasibility of photothermal therapy based on porous silicon nanoparticles (PSiNPs) in combination with a near-infrared (NIR) laser. The in-vivo animal test results showed that the murine colon carcinoma (CT-26) tumors were completely resorbed with minimal damage to surrounding healthy tissue within 5 days after PSiNPs and NIR laser treatments. In contrast, tumors in the groups treated only with PSiNPs or NIR and a control group continued to grow until the mice died. All of the mice treated with both PSiNPs and NIR remained healthy and free of tumors even 90 days after the treatment. In-vivo fluorescence imaging and the urine and feces tests revealed that PSiNPs injected intratumorally into mice were cleared mainly through the urine. The in-vivo animal test results suggest that thermotherapy based on porous silicon in combination with NIR laser irradiation can efficiently destroy cancer cells selectively without damaging the surrounding healthy cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21934604     DOI: 10.1097/CAD.0b013e32834b859c

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  2 in total

1.  In vitro cell tests of pancreatic malignant tumor cells by photothermotherapy based on DMSO porous silicon colloids.

Authors:  Chanseok Hong; Chongmu Lee
Journal:  Lasers Med Sci       Date:  2013-04-20       Impact factor: 3.161

2.  Silicon particles as trojan horses for potential cancer therapy.

Authors:  Roberto Fenollosa; Eduardo Garcia-Rico; Susana Alvarez; Rosana Alvarez; Xiang Yu; Isabel Rodriguez; Susana Carregal-Romero; Carlos Villanueva; Manuel Garcia-Algar; Pilar Rivera-Gil; Angel R de Lera; Wolfgang J Parak; Francisco Meseguer; Ramón A Alvarez-Puebla
Journal:  J Nanobiotechnology       Date:  2014-09-16       Impact factor: 10.435

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.